Diagnostics Market Research
Explore your competitors and realise your potential in the Diagnostics market. Our reports include information on Testing, Companion Markets, Imaging and In Vitro Diagnostics.
Stay up-to-date with new products added to this category
first
previous
Title  | Date  | Price |
|---|---|---|
| HSV 2 NA Tests in Italy Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| HIV Viral Load NA Tests in Italy Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| HSV 1 NA Tests in Italy Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| MAC NA Tests in Italy Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| MSSA NA Tests in Italy Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| HPV Genotyping NA Tests in Italy Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| HLA Typing NA Tests in Italy Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| HBV Viral Load NA Tests in Italy Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| HCV Genotyping NA Tests in Italy Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| HIV Genotyping NA Tests in Italy Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Her2Neu NA Tests in Italy Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| CMF Viral Load NA Tests in Italy Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Chlamydia Trachomatis (CT) NA Tests in Italy Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| RSV NA Tests in France Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Staphylococcus aureus NA Tests in France Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Epstein-Barr Virus (EBV) NA Tests in Italy Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Warfarin sensitivity (CYP2C9, VKOR1) NA Tests in France Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| VZV NA Tests in France Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Group B Streptococcus (GBS) NA Tests in Italy Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Enterovirus NA Tests in Italy Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Factor V Leiden NA Tests in Italy Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| MSSA NA Tests in France Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Parainfluenza 1, 2, 3 NA Tests in France Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Neisseria Gonorrheae (NG) NA Tests in France Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| HBV Ressistance NA Tests in Italy Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| HBV Quantitative NA Tests in Italy Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Assessment of the Molecular Diagnostic Market for 44 NA Tests in France | Apr 2009 | £8,040 |
| Warfarin sensitivity (CYP2C9, VKOR1) NA Tests in UK Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Assessment of the Molecular Diagnostic Market for 44 NA Tests in UK | Apr 2009 | £8,040 |
| BK Virus NA Tests in UK Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Assessment of the Molecular Diagnostic Market for 44 NA Tests in Italy | Apr 2009 | £8,040 |
| Technology Trends and Business Opportunities in Latin American X-Ray Market | Apr 2009 | £3,605 |
| Diagnostics & Pathology in India | Apr 2009 | £600 |
| HCV Qualitative NA Tests in UK Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Epstein-Barr Virus (EBV) NA Tests in Germany Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Enterovirus NA Tests in Germany Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Assessment of the Molecular Diagnostic Market for 44 NA Tests in Germany | Apr 2009 | £8,040 |
| Assessment of the Molecular Diagnostic Market for 44 NA Tests in Spain | Apr 2009 | £8,040 |
| HBV Quantitative NA Tests in UK Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| CMV Quant NA Tests in Italy Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Factor II NA Tests in Italy Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Group A Streptococcus (GAS) NA Tests in Italy Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Fragile X NA Tests in Italy Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Mycobacterium tuberculosis (MTB) NA Tests in France Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Chlamydia trachomatis/Neisseria gonorrheae (CT/NG) NA Tests in UK Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| HIV Qualitative NA Tests in UK Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| HBV Viral Load NA Tests in UK Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| HBV Ressistance NA Tests in UK Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| CMV Quant NA Tests in Germany Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Adenovirus NA Tests in Italy Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| VRE NA Tests in France Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| HPV Genotyping NA Tests in UK Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| HSV 1 NA Tests in UK Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| HLA Typing NA Tests in UK Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Chlamydia Trachomatis (CT) NA Tests in Spain Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| CMF Viral Load NA Tests in Spain Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| CMV Quant NA Tests in Spain Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| BK Virus NA Tests in Spain Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| RSV NA Tests in Italy Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| VRE NA Tests in Italy Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| VZV NA Tests in Italy Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Clostridium Difficile (C.diff) NA Tests in Spain Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Fragile X NA Tests in Spain Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Group B Streptococcus (GBS) NA Tests in Spain Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Fragile X NA Tests in France Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Staphylococcus aureus NA Tests in Spain Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| HPV Quantitative NA Tests in Spain Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Epstein-Barr Virus (EBV) NA Tests in France Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| RSV NA Tests in Germany Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Research Report of Chinese Diagnostic Reagent Industry, 2009 | Apr 2009 | £990 |
| Factor II NA Tests in Spain Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Mycobacterium tuberculosis (MTB) NA Tests in UK Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| MSSA NA Tests in UK Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Mycobacterium Tuberculosis Direct (MTD) NA Tests in UK Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| MRSA NA Tests in UK Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| MAC NA Tests in UK Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| HBV Quantitative NA Tests in Spain Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Group A Streptococcus (GAS) NA Tests in Spain Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| VZV NA Tests in UK Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Neisseria Gonorrheae (NG) NA Tests in Spain Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Mycobacterium tuberculosis (MTB) NA Tests in Spain Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Mycobacterium tuberculosis (MTB) NA Tests in Italy Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| MRSA NA Tests in Italy Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| BK Virus NA Tests in Italy Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Cystic Fibrosis, Mucoviscoidosis NA Tests in Italy Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Chlamydia trachomatis/Neisseria gonorrheae (CT/NG) NA Tests in Italy Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Clostridium Difficile (C.diff) NA Tests in Italy Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| MSSA NA Tests in Spain Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| MRSA NA Tests in Spain Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| VRE NA Tests in UK Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| HSV 1 NA Tests in Spain Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Pharmacodiagnostics and Personalized Medicine 2009 (Markets, Challenges, Forecasts and Key Players) | Apr 2009 | £2,105 |
| Medical Diagnostics - India | Apr 2009 | £350 |
| HIV Genotyping NA Tests in Spain Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| Adenovirus NA Tests in UK Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| HSV 2 NA Tests in Spain Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| VRE NA Tests in Spain Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| RSV NA Tests in Spain Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
| The Top 100 In Vitro Diagnostics Manufacturing Companies In Europe (2nd ed.) | Apr 2009 | £620 |
| HCV Viral Load NA Tests in Spain Assessment of the Molecular Diagnostic Market | Apr 2009 | £355 |
Filter Results by
Industry Events
2nd International Conference on Drug Discovery and Therapy
01 Feb 10 to 04 Feb 10
Dubai, United Arab Emirates
view summary >>
Advancing Biologics from the Lab to the Clinic
11 Jan 10 to 12 Jan 10
Brussels, Belgium
view summary >>
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharma Chemicals
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
